These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 4011049)
1. Lack of effect of intranigral administration of a dopamine analogue, (+/-)-3-(3-hydroxyphenyl)-N,n-propylpiperidine [(+/-)-3-PPP], on nigrostriatal dopamine neurones. Kelly E; Jenner P; Marsden CD Neurosci Lett; 1985 May; 56(1):57-62. PubMed ID: 4011049 [TBL] [Abstract][Full Text] [Related]
2. Comparison of changes in locomotor activity with striatal homovanillic acid and 3,4-dihydroxyphenylacetic acid concentrations following the bilateral intranigral injection of dopamine agonist drugs in rats. Kelly E; Jenner P; Marsden CD J Pharm Pharmacol; 1987 Mar; 39(3):196-202. PubMed ID: 2883284 [TBL] [Abstract][Full Text] [Related]
3. Differential effects of the enantiomers of 3-(3-hydroxyphenyl)-N-n-propylpiperidine (3-PPP) at dopamine receptor sites. Koch SW; Koe BK; Bacopoulos NG Eur J Pharmacol; 1983 Sep; 92(3-4):279-83. PubMed ID: 6138267 [TBL] [Abstract][Full Text] [Related]
4. An electrophysiological analysis of the actions of the 3-PPP enantiomers on the nigrostriatal dopamine system. Clark D; Engberg G; Pileblad E; Svensson TH; Carlsson A; Freeman AS; Bunney BS Naunyn Schmiedebergs Arch Pharmacol; 1985 Jun; 329(4):344-54. PubMed ID: 4033804 [TBL] [Abstract][Full Text] [Related]
5. (+)- and (-)-3-PPP exhibit different intrinsic activity at striatal dopamine autoreceptors controlling dopamine synthesis. Clark D; Hjorth S; Carlsson A Eur J Pharmacol; 1984 Oct; 106(1):185-9. PubMed ID: 6099268 [TBL] [Abstract][Full Text] [Related]
6. In vivo voltammetric study of dopamine release in the striatum following microinjection of apomorphine into the substantia nigra zona reticulata. Kamata K; Sugimoto A; Kameyama T Jpn J Pharmacol; 1986 Mar; 40(3):472-7. PubMed ID: 3712872 [TBL] [Abstract][Full Text] [Related]
7. Behavioral and biochemical effects of subchronic treatment with (-)3-(3-hydroxyphenyl)-N-n-propylpiperidine in the rat: dopamine receptor sensitivity and tolerance. Ahlenius S; Hillegaart V; Magnusson O; Lundström J J Neural Transm; 1984; 60(2):103-13. PubMed ID: 6491654 [TBL] [Abstract][Full Text] [Related]
8. Pharmacological profiles of the putative dopamine autoreceptor agonists 3-PPP and TL-99. Martin GE; Haubrich DR; Williams M Eur J Pharmacol; 1981 Nov; 76(1):15-23. PubMed ID: 7318920 [TBL] [Abstract][Full Text] [Related]
9. 7-[3-(4-[2,3-Dimethylphenyl]piperazinyl)propoxy]-2(1H)-quinolinone (OPC-4392), a presynaptic dopamine autoreceptor agonist and postsynaptic D2 receptor antagonist. Yasuda Y; Kikuchi T; Suzuki S; Tsutsui M; Yamada K; Hiyama T Life Sci; 1988; 42(20):1941-54. PubMed ID: 3130534 [TBL] [Abstract][Full Text] [Related]
10. Effects of apomorphine and (+/-)-3-(3-hydroxyphenyl)-N-n-propylpiperidine, injected into the striatum, on the caudate spindle in the rat. Hashimoto S; Okuyama S; Aihara H Neuropharmacology; 1987 Jul; 26(7A):663-7. PubMed ID: 2888038 [TBL] [Abstract][Full Text] [Related]
11. Behavioural effects mediated by unilateral nigral dopamine receptor stimulation in the rat. Kelly E; Jenner P; Marsden CD Exp Brain Res; 1984; 55(2):243-52. PubMed ID: 6611272 [TBL] [Abstract][Full Text] [Related]
12. Different actions of TL-99 and 3-PPP in producing contraversive turning in the 6-OHDA-lesioned rat. Martin GE; Jones JH; Bendesky RJ Eur J Pharmacol; 1983 Sep; 92(3-4):275-8. PubMed ID: 6138266 [TBL] [Abstract][Full Text] [Related]
13. Effects of intraperitoneal administration of apomorphine and the isomers of 3-(1-propyl-3-piperidinyl)phenol on the firing activity of substantia nigra dopamine neurons: comparison of agonist efficacies and development of acute tolerance. Meltzer LT; Christoffersen CL Neuropharmacology; 1988 Sep; 27(9):933-42. PubMed ID: 3185867 [TBL] [Abstract][Full Text] [Related]
14. Relative selectivity of 6,7-dihydroxy-2-dimethylaminotetralin, N-n-propyl-3-(3-hydroxyphenyl)piperidine, N-n-propylnorapomorphine and pergolide as agonists at striatal dopamine autoreceptors and postsynaptic dopamine receptors. Claustre Y; Fage D; Zivkovic B; Scatton B J Pharmacol Exp Ther; 1985 Feb; 232(2):519-25. PubMed ID: 2857197 [TBL] [Abstract][Full Text] [Related]
15. Central dopamine receptor agonist and antagonist actions of the enantiomers of 3-PPP. Hjorth S; Carlsson A; Clark D; Svensson K; Wikström H; Sanchez D; Lindberg P; Hacksell U; Arvidsson LE; Johansson A Psychopharmacology (Berl); 1983; 81(2):89-99. PubMed ID: 6415751 [TBL] [Abstract][Full Text] [Related]
16. A behavioural study of the changes in the central nervous system of mice after subchronic treatment with the selective dopamine autoreceptor agonist 3-PPP (dl-3-[3-hydroxyphenyl]-N-n-propylpiperidine). Jackson D; Carlsson A; Hjorth S; Lindberg P J Neural Transm; 1982; 53(4):233-45. PubMed ID: 6286867 [TBL] [Abstract][Full Text] [Related]